Update     | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |     Dates

WARNING: This site deals only with the corporate corruption of science, and makes no inference about the motives or activities of individuals involved.
    There are many reasons why individuals become embroiled in corporate corruption activities - from political zealotry to over-enthusiastic activism; from gullibility to greed.
    Please read the OVERVIEW carefully, and make up your own mind.



Council for Tobacco Research
Clarence Cook Little
Hockett dictum
Gentlemen's agreement

RESEARCH HELP:   If you wish to help research or write for this project, we are always looking for volunteers.
E-mail the editor (below).

[Temporary: while site is under construction]  

Bio-Research Laboratories    

BioResearch Laboratories was a Boston-based research facility run by a tobacco industry biochemical consultant and Special Project #4 recipient, Dr LGS. Rao. He originally worked for the industry through the Department of Steroid Biochemistry, Royal Infirmary in Glascow, Scotland.


1964 Oct: English tobacco executive Geoffrey Todd led a small delegation to the UK. These are their comments on the Council for Tobacco Research and its head, Dr Clarence Cook Little after a visit in September-October 1964.

Dr Little was critical and bitter about TRC's skin painting experiments at Harrogate [in the UK]. He has been engaged in 'intensive in-fighting with Dr Wynder and his skin painting experments" and regards "the Harrogate experiments as letting-down of his side. This of course, has not prevented CTR commissioning Bio-Research Inc. to do mouse skin painting experiments."

    The industry had consistently attacked the use of skin-painting following Wynder's first study. The CTR promoted the "Hockett dictum" which said that this cancer-assay technique was the "wrong method and wrong chemical applied to the wrong animal."

    Later in the report they comment on one aspect of the Gentleman's Agreement not to do 'biological research' in the USA where adverse findings could be exposed during lawsuit discovery processes
As we know, CTR supports only fundamental research of little relevance to present day problems. Pharmacological research into the effects of nicotine is about as close as the research comes to a cigarette.
    While a remark made to us implied that one manufacturer might be doing some biological research in his own laboratory, the practice is to contract out this work.

    The following arrangements are believed to have been made :
    • American Tobacco Co. — Dr Larson (Medical School of Virginia).
    • Philip Morris — Food & Drug Research Inc., of Long Island, and another firm.
    • Liggett & Myers — AD Little Co., Boston
    • Lorillard — Bio-Research Inc., Boston, and Dr. Dalhamn (Stockholm).

Dr Wynder also informed GFT [Geoffrey Todd] that the Armour Research Foundation waa doing biological research for some cigarette manufacturer.